Relmada Therapeutics

RLMD

Relmada Therapeutics has been a target of short sellers for a while. The current short interest of 11.42% is significantly above the average of the last 12 months (6.16%).

Short Interest Trend

Share Price

Total NSP

11.42%

-1.16%

vs. last month

Also interesting? All insider buys at Relmada Therapeutics

Found an error? Questions? Ideas?